WPRIM Management System> DCMS> Chinese Journal of Clinical Oncology> 2017> 44> 13

Volume: 44 Issue: 13

1. Manifestation and therapies of EGFRI-induced dermatological toxicities Page:673—676
2. Efficacy and safety of multiple-dose 5-HT3 receptor antagonists in preventing multi-day-based and highly emetogenic chemotherapy-induced nausea and vomiting Page:667—672
3. PEG-rhG-CSF for peripheral blood stem cell mobilization in patients with relapsed or refractory malignant lymphoma Page:662—666
4. Comparison of rectal cancer tumor volume parameters measured by MRI sequences and CT with those by pathological specimen Page:656—661
5. Mechanisms of differentiation of omental-adipose stromal cells promoted by gastric cancer cells Page:651—655
6. Histone deacetylase inhibitor down-regulated the expression of HER-2 in breast cancer through the changes in miRNA Page:644—648
7. Progress on breast cancer research in patients aged 25 years and younger Page:640—643
8. Advances of target therapy in hormone-receptor-positive breast cancer Page:635—639
9. Clinical research progress on treatments for HER-2-positive breast cancer Page:630—634
10. Clinical progress and future of targeted therapy for breast cancer Page:625—629

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.